Skip to content

By playing, you agree to uListen's Terms and Privacy Policy and YouTube's Terms of Service.

a16za16z

7 More Healthy Years: What We Can Learn from Super Agers

American healthcare is in crisis—but what if we could change the system by preventing disease before it starts?

Vijay PandehostDr. Eric Topolguest
May 26, 202521mWatch on YouTube ↗

Summaries, chapters, transcripts, and FAQs on this page are made by uListen, not YouTube.

At a glance

WHAT IT’S REALLY ABOUT

Blueprint for seven extra healthy years through prevention and AI

  1. Topol argues the most realistic near-term longevity win is not “reversing aging” but preventing cancer, cardiovascular disease, and Alzheimer’s to extend healthspan by roughly seven years.
  2. A central thesis is that these diseases incubate for decades and share immune dysfunction/inflammation roots, making early risk detection and intervention more powerful than late-stage treatment.
  3. He frames a new preventive standard of care built on “intelligent partitioning of risk,” combining omics, organ/molecular aging clocks, biomarkers, and AI to personalize surveillance and action.
  4. The conversation highlights breakthroughs in immune-reset cell therapies and personalized cancer vaccines as signs that immunology will increasingly enable both treatment and prevention.
  5. They critique today’s U.S. system as “sick care,” citing costly age-based mass screening with low yield, and propose shifting to risk-based screening to improve outcomes and reduce waste.

IDEAS WORTH REMEMBERING

5 ideas

The biggest attainable longevity gain is extending healthspan, not lifespan.

Topol emphasizes preventing the Big Three (cancer, heart disease, Alzheimer’s) can plausibly add ~seven healthy years without requiring “aging reversal,” which remains unproven in humans.

Age-related diseases are long-incubating and therefore forecastable.

Because many cancers, cardiovascular disease, and neurodegeneration develop over ~20 years, the best leverage is early detection of risk trajectories and intervening before symptoms.

Prevention requires AI because the data is inherently multimodal.

Topol positions AI as the “first dimension” since integrating omics, organ clocks, biomarkers (e.g., p-tau217), clinical history, and environmental exposures exceeds human analytic capacity.

Immune modulation is emerging as a cornerstone of both curing and preventing disease.

Examples include B-cell depletion “resetting” autoimmune disease and personalized cancer vaccines/immune therapies, pointing to a future where tuning immunity can suppress tumors and reduce age-related vulnerability.

“Lifestyle plus” expands prevention beyond diet, exercise, and sleep.

He adds environmental burdens (air pollution, micro/nanoplastics, forever chemicals) and factors like time in nature, arguing comprehensive exposure management will matter alongside behavior.

WORDS WORTH SAVING

5 quotes

We have a path to prevention. It isn't reversing aging. It's just preventing the age-related morbidities of the Big Three.

— Dr. Eric Topol

Seven years? Who wouldn't take seven years? I hope we'll seize this opportunity because we may never get another one like this for a long time.

— Dr. Eric Topol

Uh, the Ozempic, you know, uh, Zepbound world- ... it's the most momentous drug class in medical history, and we've only seen part of the story so far.

— Dr. Eric Topol

If we didn't have the, the science of aging and the AI, we'd be nowhere. We wouldn't be talking about this today. I wouldn't have written a book.

— Dr. Eric Topol

Uh, we're ingrained in, in, in stupidity.

— Dr. Eric Topol

Read the available transcript
Super agers and the Wellderly findings (limited genomic signal)Prevention vs reversing aging; focusing on the Big ThreeFive dimensions of health (AI, omics, immune/cell therapies, biomarkers/clocks, lifestyle-plus)Multimodal AI for integrating longitudinal health data and predictionImmune system as root lever: inflammation, senescence, immunome measurementCancer prevention: polygenic risk scores and multi-cancer early detectionGLP-1 drugs as a chronic-disease inflection point and their spillover benefits

SPEAKERS

  • Vijay Pande

    host

    General Partner at Andreessen Horowitz (a16z) focused on bio/health and technology.

  • Dr. Eric Topol

    guest

    Cardiologist and researcher at Scripps Research, known for work on digital medicine and longevity/healthspan.

High quality AI-generated summary created from speaker-labeled transcript.

Get more out of YouTube videos.

Read along on your phone, search it beside the video, or ask your favorite AI app what was said.